Most cited article(s)

  • The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults
    Alvin Lee Day, MD, Kevin L. Winthrop, MD, MPH and Jeffrey R. Curtis, MD, MS, MPH
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 695-703; DOI: https://doi.org/10.3949/ccjm.87a.20056

    Patients can have variable responses to vaccines, depending on the vaccine and the DMARD.

  • Sepsis and septic shock: Guideline-based management
    Siddharth Dugar, MD, Chirag Choudhary, MD, MBA and Abhijit Duggal, MD, MPH, MSc, FACP
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 53-64; DOI: https://doi.org/10.3949/ccjm.87a.18143

    Sepsis requires prompt recognition, appropriate antibiotics, careful hemodynamic support, and control of the source of infection.

  • Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
    Chin Hee Kim, MD and Zobair M. Younossi, MD, MPH
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 721-728;

    As we get heavier, our livers get fattier. Despite an explosion of research on nonalcoholic fatty liver disease and gains in understanding its epidemiology and pathogenesis, a number of issues remain unresolved, including how to treat it.

  • When patients on warfarin need surgery
    Amir K. Jaffer, MD, Daniel J. Brotman, MD and Nkem Chukwumerije, MD
    Cleveland Clinic Journal of Medicine November 2003, 70 (11) 973-984;

    How to manage anticoagulation in the perioperative period is controversial; we offer our approach.

  • But how many people died? Health outcomes in perspective
    Vinay Prasad, MD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 146-150; DOI: https://doi.org/10.3949/ccjm.82a.14058

    Before dispensing advice, we should know the effect of what we recommend on all meaningful outcomes.

  • Recognizing and treating diabetic autonomic neuropathy
    Aaron I. Vinik, MD, PhD and Tomris Eras, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 928-944;

    Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.

  • Recent trials of antioxidant therapy: What should we be telling our patients?
    Bibi I. Hasnain, MD and Arshag D. Mooradian, MD
    Cleveland Clinic Journal of Medicine April 2004, 71 (4) 327-334;

    Evidence does not support the indiscriminate use of vitamins A, C, or E or beta carotene to prevent or reduce cardiovascular disease.

  • Small fiber neuropathy: A burning problem
    Jinny Tavee, MD and Lan Zhou, MD, PhD
    Cleveland Clinic Journal of Medicine May 2009, 76 (5) 297-305; DOI: https://doi.org/10.3949/ccjm.76a.08070
  • Preventing and treating orthostatic hypotension: As easy as A, B, C
    Juan J. Figueroa, MD, Jeffrey R. Basford, MD, PhD and Phillip A. Low, MD
    Cleveland Clinic Journal of Medicine May 2010, 77 (5) 298-306; DOI: https://doi.org/10.3949/ccjm.77a.09118

    Easy-to-remember management recommendations, using a combination of effective drug and nondrug treatments.

  • Systemic diseases associated with intermediate uveitis
    Steven A. Boskovich, MD, Careen Y. Lowder, MD, PhD, David M. Meisler, MD and Froncie A. Gutman, MD
    Cleveland Clinic Journal of Medicine November 1993, 60 (6) 460-465;

    Multiple sclerosis, inflammatory bowel disease, thyroid abnormalities, and possible Epstein-Barr virus infection were among the findings in 26 of 83 intermediate uveitis patients.

Pages